Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06624800
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-26
Brief Title:
The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents A Pragmatic Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Shoulder chuna
Brief Summary:
This study is a double blind randomized controlled trail conditiondisease Patient with acute shoulder pain and restricted movement due to a traffic accident treatmentintervention Chuna therapy for the shoulder including integrated Korean medicine treatment
Detailed Description:
The investigators intend to conduct a randomized controlled trial to evaluate the effectiveness of Chuna therapy for shoulder pain and restricted movement caused by a traffic accident The study will involve administering shoulder Chuna therapy from the second day of hospitalization until discharge with the aim of assessing its effects on shoulder pain relief and recovery of range of motion Although the effectiveness of Korean medicine for treating trauma from traffic accidents has been well studied the research has largely focused on spinal conditions such as those affecting the cervical and lumbar spine Likewise most studies on Chuna therapy have centered around spinal disorders Through this study the investigators aim to explore the therapeutic effects of shoulder Chuna therapy an area that has not been extensively researched
1 The effectiveness of shoulder Chuna therapy will be evaluated by observing and comparing changes in pain range of motion limitation functional disability quality of life and patient satisfaction between the shoulder Chuna group treatment group and the Korean integrative medicine group control group
2 Investigators will assess the treatment effects of shoulder Chuna therapy on shoulder pain and restricted movement by observing improvements in initial NRS VAS scores SPADI and ROM in the shoulder Chuna group treatment group compared to the Korean integrative medicine group control group
3 The total number of treatment sessions and the degree of improvement will be observed and compared between the shoulder Chuna group treatment group and the Korean integrative medicine group control group to evaluate the effectiveness of the treatment frequency
4 The safety of the therapy will be assessed by investigating adverse reactions in both the shoulder Chuna group treatment group and the Korean integrative medicine group control group
1 The effectiveness of shoulder Chuna therapy will be evaluated by observing and comparing changes in pain range of motion limitation functional disability quality of life and patient satisfaction between the shoulder Chuna group treatment group and the Korean integrative medicine group control group
2 Investigators will assess the treatment effects of shoulder Chuna therapy on shoulder pain and restricted movement by observing improvements in initial NRS VAS scores SPADI and ROM in the shoulder Chuna group treatment group compared to the Korean integrative medicine group control group
3 The total number of treatment sessions and the degree of improvement will be observed and compared between the shoulder Chuna group treatment group and the Korean integrative medicine group control group to evaluate the effectiveness of the treatment frequency
4 The safety of the therapy will be assessed by investigating adverse reactions in both the shoulder Chuna group treatment group and the Korean integrative medicine group control group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None